株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

多血小板血漿の世界市場測 2014-2020年 (純粋な多血小板血漿、多白血球・多血小板血漿、多白血球・多血小板フィブリン)

Platelet Rich Plasma Market (By Types, By Origin, By Applications) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020

発行 Transparency Market Research 商品コード 326014
出版日 ページ情報 英文 102 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
多血小板血漿の世界市場測 2014-2020年 (純粋な多血小板血漿、多白血球・多血小板血漿、多白血球・多血小板フィブリン) Platelet Rich Plasma Market (By Types, By Origin, By Applications) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020
出版日: 2015年01月30日 ページ情報: 英文 102 Pages
概要

多血小板血漿(PRP)は、血小板を通常の4倍から8倍の濃度に高めた血漿を製品化したもので、「血小板プラズマジェル」などの呼称で整形外科、スポーツ医学、神経外科、心胸外科をはじめ、さまざまな分野で障害治療に利用されるほか、美容産業でも広範に活躍しています。

当レポートでは、多血小板血漿の世界市場に注目し、その現状と今後の有望性を考察すべく、世界全体および各地域における取引規模の推移を検証・予測するほか、市場の推進・抑制要因、発展機会、産業バリューチェーン、競合環境、市場求心力などについての分析情報、そして主要参入企業のプロファイルをまとめています。

第1章 はじめに

第2章 エグゼクティブサマリー

  • 市場寸見:多血小板血漿の世界市場
  • 多血小板血漿の世界市場 - 形式別(単位:100万米ドル)
  • 多血小板血漿の世界市場 - 生成源別(単位:100万米ドル)
  • 多血小板血漿の世界市場 - 用途別(単位:100万米ドル)
  • 比較分析:多血小板血漿の世界市場 - 地域別(価額伸び率)

第3章 市場概要:多血小板血漿の世界市場

  • イントロダクションと市場の定義
  • イベントインパクト分析
  • 市場動態
    • 市場推進要因
      • 整形外科・スポーツ障害の多発とそれに伴う外科手術の増加で弾みを増す市場
      • 美容整形手術の増加で加速に向かう市場
      • 技術進歩と新型機器認可が世界的な追い風に
      • 新興地域における多血小板血漿製品・機器に対する認知拡大で期待される市場成長
    • 市場抑制要因
      • 高額な製品・機器コストが市場成長の足枷に
      • 市場成長を妨げかねない手術失敗と疾患伝播(同種異系血、同種血を使用する場合)
    • 機会
      • 新たな日筋を開く先端技術機器および新応用分野の開発
  • 多血小板血漿(PRP)世界市場のPorterのファイブフォース分析
  • バリューチェーン分析
  • 規制状況
  • 市場求心力分析:多血小板血漿(PRP)の世界市場 - 地域別
  • 競合環境
    • 多血小板血漿(PRP)世界市場シェア分析 - 主要企業別(価額構成比)

第4章 多血小板血漿(PRP)の世界市場 - 形式別

  • 概要
    • 世界市場収入 - 形式別(単位:100万米ドル)
  • 純粋多血小板血漿(P-PRP)
  • 多白血球・多血小板血漿(L-PRP)
  • 純粋多血小板フィブリン(L-PRF)および多白血球・多血小板フィブリン(L-PRF)

第5章 多血小板血漿(PRP)の世界市場 - 生成源別

  • 概要
    • 世界市場収入 - 生成源別(単位:100万米ドル)
  • 自己血多血小板血漿
  • 同種異系血多血小板血漿
  • 同種血多血小板血漿

第6章 多血小板血漿(PRP)の世界市場 - 用途別

  • 概要
    • 世界市場収入 - 用途別(単位:100万米ドル)
  • 整形外科
  • 美容外科
  • 一般外科
  • 神経外科
  • その他の外科手術(泌尿器科、心胸外科、口腔顎顔面外科、歯周科)

第7章 多血小板血漿(PRP)の世界市場 - 地域別

  • 概要
    • 世界市場収入 - 地域別(単位:100万米ドル)
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第8章 提言

  • 市場シェア拡大に新たな道筋を開く新興市場への投資
  • 市場成長を加速する新多血小板血漿機器の開発と新応用分野の発見
  • 市場成長に弾みを付ける先進技術多血小板血漿機器の商業化および推進

第9章 企業プロファイル(企業概要、財務概況、製品ポートフォリオ、事業戦略、最新展開)

  • AdiStem Ltd.
  • Arteriocyte Medical Systems, Inc.
  • Arthrex, Inc.
  • Biomet, Inc.
  • Cesca Therapeutics, Inc.
  • DePuy Synthes, Inc. (DePuy Mitek Sports Medicine)
  • Dr. PRP America LLC
  • EmCyte Corporation
  • Exactech, Inc.
  • Harvest Technologies Corp.
  • Nuo Therapeutics, Inc. (Cytomedix, Inc.)
  • Regen Lab SA
  • Stryker Corporation
目次

Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration. PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel. PRP is an effective treatment to treat various diseases such as orthopedic diseases, sports injuries, neurological diseases and cardiothoracic diseases. In addition, PRP therapy has an extensive application in cosmetic industry. This report studies the current scenario as well as future market potential for PRP globally.

The market overview section of the report comprises qualitative analysis of the overall PRP market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis. In addition, various analyses such as event impact analysis, regulatory scenario and value chain analysis has also been provided. Event impact analysis encompasses the major events occurred in past decade and are expected to occur during the forecast period and are likely to affect the market dynamics positively or negatively. Value chain analysis includes the study of major steps involved in the PRP devices preparation and distribution. Regulatory scenario includes the study of different regulatory norms and procedures that regulate the approval and commercialization of PRP devices and products.

The global PRP market has been segmented on the basis of types, origins and applications. On the basis of types, the global PRP market is categorized as pure-PRP (P-PRP), leukocyte-rich PRP (L-PRP) and pure PRF/leukocyte-rich PRF (L-PRF). Moreover, on the basis of origin, the PRP market has been segmented into autologus, homologus and allogenic PRP. Furthermore, on the basis of applications, the global PRP market has been classified as neurosurgery, cosmetic surgery, orthopedic surgery, general surgery and others (cardiothoracic surgery, urology, periodontal surgery and oral and maxillofacial surgery). The market for these types, origins and applications has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (USD million) for each of these segments have been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2014 to 2020.

Geographically, the PRP market has been classified into four segments namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2012 to 2020, in terms of origin, types and applications, along with the CAGR (%) for the forecast period 2014 to 2020.

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global PRP market, in terms of percentage share in 2013 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report concludes with the profiles of major players in the global PRP market such as AdiStem Ltd., Arteriocyte Medical Systems, Inc., Arthrex, Inc., Biomet, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., Dr. PRP America LLC., EmCyte Corporation, Exactech, Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA, and Stryker Corporation. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

Global Platelet Rich Plasma (PRP) Market is segmented as follows:

Global Platelet Rich Plasma (PRP) Market, by Types

  • Pure-Platelet Rich Plasma (P-PRP)
  • Leukocyte-Platelet Rich Plasma (L-PRP)
  • Leukocyte-Platelet Rich Fibrin (L-PRF)

Global Platelet Rich Plasma (PRP) Market, by Origin

  • Autologus
  • Homologus
  • Allogenic

Global Platelet Rich Plasma (PRP) Market, by Applications

  • Orthopedic Surgery
  • Cosmetic Surgery
  • General Surgery
  • Neurosurgery
  • Other Surgeries (Oral and Maxillofacial, Cardiothoracic, Periodontal and Urological)

Global Platelet Rich Plasma (PRP) Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Sources
      • 1.3.1.1 Secondary Research
      • 1.3.1.2 Primary Research
    • 1.3.2 Assumptions

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global PRP Market (2013 & 2020)
  • 2.2 Global PRP Market, by Types, 2013 (USD Million)
  • 2.3 Global PRP Market, by Origin, 2013 (USD Million)
  • 2.4 Global PRP Market, by Applications, 2013 (USD Million)
  • 2.5 Comparative Analysis: Global PRP Market, By Geography, 2013 & 2020 (Value %)

Chapter 3 Market Overview: Platelet Rich Plasma Market

  • 3.1 Introduction and Market Definition
  • 3.2 Event Impact Analysis
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Increase in prevalence of orthopedic diseases and sports injuries and thereby rise in number of surgeries fuel market growth
      • 3.3.1.2 Increasing cosmetic surgeries are likely to accelerate market growth
      • 3.3.1.3 Technological advancements and regulatory approvals for new devices are contributing to the growth of the global PRP market
      • 3.3.1.4 Increasing awareness about PRP products and devices in emerging economies would accelerate market growth
    • 3.3.2 Market Restraints
      • 3.3.2.1 High cost of PRP products and devices would restrain market growth
      • 3.3.2.2 Threat of therapy failure and disease transfer (in case of allogenic and homologus PRP) could offer the resistance to market growth
    • 3.3.3 Opportunities
      • 3.3.3.1 Development of technologically advanced devices and new application areas of PRP technology would open new avenues
  • 3.4 Porters Five Force Analysis for the Global Platelet Rich Plasma (PRP) Market
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Threat of Substitutes
    • 3.4.4 Threat of New Entrants
    • 3.4.5 Competitive Rivalry
  • 3.5 Value Chain Analysis
  • 3.6 Regulatory Scenario
  • 3.7 Market Attractiveness Analysis: Global Platelet Rich Plasma (PRP) Market, by Geography, 2013
  • 3.8 Competitive Landscape
    • 3.8.1 Global PRP Market Share Analysis, by Key Players, 2013 (Value %)

Chapter 4 Global Platelet-Rich Plasma Market, by Types

  • 4.1 Overview
    • 4.1.1 Global PRP Market Revenue, by Types, 2012 - 2020 (USD Million)
  • 4.2 Pure Platelet-Rich Plasma (P-PRP)
    • 4.2.1 Global Pure Platelet-Rich Plasma Market Revenue, 2012 - 2020, (USD Million)
  • 4.3 Leukocyte-Rich Platelet-Rich Plasma (L-PRP)
    • 4.3.1 Global Leukocyte-Rich Platelet Rich Plasma Market Revenue, 2012 - 2020, (USD Million)
  • 4.4 Pure Platelet-Rich Fibrin (P-PRF)/ Leukocyte-Rich Platelet-Rich Fibrin (L-PRF)
    • 4.4.1 Global Leukocyte-Rich Platelet Rich Fibrin Market Revenue, 2012 - 2020, (USD Million)

Chapter 5 Global Platelet-Rich Plasma Market, by Origin

  • 5.1 Overview
    • 5.1.1 Global PRP Market Revenue, by Origin, 2012 - 2020 (USD Million)
  • 5.2 Autologus Platelet-Rich Plasma
    • 5.2.1 Global Autologus Platelet-Rich Plasma Market Revenue, 2012 - 2020, (USD Million)
  • 5.3 Allogenic Platelet-Rich Plasma
    • 5.3.1 Global Allogenic Platelet-Rich Plasma Market Revenue, 2012 - 2020, (USD Million)
  • 5.4 Homologus Platelet-Rich Plasma
    • 5.4.1 Global Homologus Platelet-Rich Plasma Market Revenue, 2012 - 2020, (USD Million)

Chapter 6 Global Platelet-Rich Plasma Market, by Applications

  • 6.1 Overview
    • 6.1.1 Global PRP Market Revenue, by Applications, 2012 - 2020 (USD Million)
  • 6.2 Orthopedic Surgery
    • 6.2.1 Global Orthopedic Surgery Market Revenue, 2012 - 2020, (USD Million)
  • 6.3 Cosmetic Surgery
    • 6.3.1 Global Cosmetic Surgery Market Revenue, 2012 - 2020, (USD Million)
  • 6.4 General Surgery
    • 6.4.1 Global General Surgery Market Revenue, 2012 - 2020, (USD Million)
  • 6.5 Neurosurgery
    • 6.5.1 Global Neurosurgery Market Revenue, 2012 - 2020, (USD Million)
  • 6.6 Other Surgeries (Urology, Cardiothoracic, Oral & Maxillofacial and Periodontal)
    • 6.6.1 Global Other Surgeries Market Revenue, 2012 - 2020, (USD Million)

Chapter 7 Global Platelet Rich Plasma Market, by Geography

  • 7.1 Overview
    • 7.1.1 Global PRP Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • 7.2 North America
    • 7.2.1 North America PRP Market, by Types, 2012 - 2020 (USD Million)
    • 7.2.2 North America PRP Market, by Origin, 2012 - 2020 (USD Million)
    • 7.2.3 North America PRP Market, by Applications, 2012 - 2020 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe PRP Market, by Types, 2012 - 2020 (USD Million)
    • 7.3.2 Europe PRP Market, by Origin, 2012 - 2020 (USD Million)
    • 7.3.3 Europe PRP Market, by Applications, 2012 - 2020 (USD Million)
  • 7.4 Asia-Pacific
    • 7.4.1 Asia-Pacific PRP Market, by Types, 2012 - 2020 (USD Million)
    • 7.4.2 Asia-Pacific PRP Market, by Origin, 2012 - 2020 (USD Million)
    • 7.4.3 Asia-Pacific PRP Market, by Applications, 2012 - 2020 (USD Million)
  • 7.5 Rest of the World (RoW)
    • 7.5.1 RoW PRP Market, by Types, 2012 - 2020 (USD Million)
    • 7.5.2 RoW PRP Market, by Origin, 2012 - 2020 (USD Million)
    • 7.5.3 RoW PRP Market, by Applications, 2012 - 2020 (USD Million)

Chapter 8 Recommendations

  • 8.1 Investment in emerging markets would open new avenues to accentuate market share
  • 8.2 Development of new PRP devices and discovery of new application areas would fuel market growth
  • 8.3 Commercialization and promotion of technologically advanced PRP devices to boost market growth

Chapter 9 Company Profiles

  • 9.1 AdiStem Ltd.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Overview
    • 9.1.3 Product Portfolio
    • 9.1.4 Business Strategies
    • 9.1.5 Recent Developments
  • 9.2 Arteriocyte Medical Systems, Inc.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Overview
    • 9.2.3 Product Portfolio
    • 9.2.4 Business Strategies
    • 9.2.5 Recent Developments
  • 9.3 Arthrex, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Overview
    • 9.3.3 Product Portfolio
    • 9.3.4 Business Strategies
    • 9.3.5 Recent Developments
  • 9.4 Biomet, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Overview
    • 9.4.3 Product Portfolio
    • 9.4.4 Business Strategies
    • 9.4.5 Recent Developments
  • 9.5 Cesca Therapeutics, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Overview
    • 9.5.3 Product Portfolio
    • 9.5.4 Business Strategies
    • 9.5.5 Recent Developments
  • 9.6 DePuy Synthes, Inc. (DePuy Mitek Sports Medicine)
    • 9.6.1 Company Overview
    • 9.6.2 Financial Overview
    • 9.6.3 Product Portfolio
    • 9.6.4 Business Strategies
    • 9.6.5 Recent Developments
  • 9.7 Dr. PRP America LLC
    • 9.7.1 Company Overview
    • 9.7.2 Financial Overview
    • 9.7.3 Product Portfolio
    • 9.7.4 Business Strategies
    • 9.7.5 Recent Developments
  • 9.8 EmCyte Corporation
    • 9.8.1 Company Overview
    • 9.8.2 Financial Overview
    • 9.8.3 Product Portfolio
    • 9.8.4 Business Strategies
    • 9.8.5 Recent Developments
  • 9.9 Exactech, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Overview
    • 9.9.3 Product Portfolio
    • 9.9.4 Business Strategies
    • 9.9.5 Recent Developments
  • 9.10 Harvest Technologies Corp.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Overview
    • 9.10.3 Product Portfolio
    • 9.10.4 Business Strategies
    • 9.10.5 Recent Developments
  • 9.11 Nuo Therapeutics, Inc. (Cytomedix, Inc.)
    • 9.11.1 Company Overview
    • 9.11.2 Financial Overview
    • 9.11.3 Product Portfolio
    • 9.11.4 Business Strategies
    • 9.11.5 Recent Developments
  • 9.12 Regen Lab SA
    • 9.12.1 Company Overview
    • 9.12.2 Financial Overview
    • 9.12.3 Product Portfolio
    • 9.12.4 Business Strategies
    • 9.12.5 Recent Developments
  • 9.13 Stryker Corporation
    • 9.13.1 Company Overview
    • 9.13.2 Financial Overview
    • 9.13.3 Product Portfolio
    • 9.13.4 Business Strategies
    • 9.13.5 Recent Developments

List of Figures

  • FIG. 1 Market Segmentation : Platelet Rich Plasma (PRP) Market
  • FIG. 2 Global PRP Market, by Types, 2013 (USD Million)
  • FIG. 3 Global PRP Market, by Origin, 2013 (USD Million)
  • FIG. 4 Global PRP Market, by Applications, 2013 (USD Million)
  • FIG. 5 Comparative Analysis: Global PRP Market, by Geography, 2013 & 2020 (Value %)
  • FIG. 6 Porter's Five Forces Analysis: Global Platelet Rich Plasma (PRP) Market
  • FIG. 7 Value Chain Analysis for Platelet Rich Plasma Market
  • FIG. 8 Market Attractiveness Analysis: Global Platelet Rich Plasma Market, by Geography, 2013
  • FIG. 9 Global PRP Market Share Analysis, by Key Players, 2013 ( Value %)
  • FIG. 10 Global Pure Platelet-Rich Plasma Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 11 Global Leukocyte- Rich Platelet Rich Plasma Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12 Global Leukocyte- Rich Platelet Rich Fibrin Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 13 Global Autologus Platelet-Rich Plasma Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14 Global Allogenic Platelet-Rich Plasma Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 15 Global Homologus Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16 Global Orthopedic Surgery Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 17 Global Cosmetic Surgery Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 18 Global General Surgery Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 19 Global Neurosurgery Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 20 Global Other Surgeries Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 21 Biomet, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 22 Cesca Therapeutics, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 23 Exactech, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 24 Nuo Therapeutics, Inc. (Cytomedix, Inc.): Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 25 Stryker Corporation: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global PRP Market (2013 & 2020)
  • TABLE 2 Global PRP Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 3 Global PRP Market Revenue, by Origin, 2012 - 2020 (USD Million)
  • TABLE 4 Global PRP Market Revenue, by Applications, 2012 - 2020 (USD Million)
  • TABLE 5 Global PRP Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • TABLE 6 North America PRP Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 7 North America PRP Market Revenue, by Origin, 2012 - 2020 (USD Million)
  • TABLE 8 North America PRP Market Revenue, by Applications, 2012 - 2020 (USD Million)
  • TABLE 9 Europe PRP Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 10 Europe PRP Market Revenue, by Origin, 2012 - 2020 (USD Million)
  • TABLE 11 Europe PRP Market Revenue, by Applications, 2012 - 2020 (USD Million)
  • TABLE 12 Asia-Pacific PRP Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 13 Asia-Pacific PRP Market Revenue, by Origin, 2012 - 2020 (USD Million)
  • TABLE 14 Asia-Pacific PRP Market Revenue, by Applications, 2012 - 2020 (USD Million)
  • TABLE 15 RoW PRP Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 16 RoW PRP Market Revenue, by Origin, 2012 - 2020 (USD Million)
  • TABLE 17 RoW PRP Market Revenue, by Applications, 2012 - 2020 (USD Million)
Back to Top